The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Function of BRCA1 in the DNA Damage Response Is Mediated by ADP-Ribosylation
Open accessAbstract
SUMMARY Carriers of BRCA1 germline mutations are predisposed to breast and ovarian cancers. Accumulated evidence shows that BRCA1 is quickly recruited to DNA lesions and plays an important role in the DNA damage response. However, the mechanism by which BRCA1 is recruited to DNA damage sites remains elusive. BRCA1 forms a Ring-domain heterodimer with BARD1, a major partner of BRCA1 that contains tandem BRCT motifs. Here, we identify the BRCTs of BARD1 as a poly(ADP-ribose) (PAR)-binding module. The binding of the BARD1 BRCTs to PAR targets the BRCA1/BARD1 heterodimer to DNA damage sites. Thus, our study uncovers a PAR-dependent mechanism of rapid recruitment of BRCA1/BARD1 to DNA damage sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Murai, J., Huang, S.-Y. N., Das, B. B., Renaud, A., Zhang, Y., Doroshow, J. H., Ji, J., Takeda, S., & Pommier, Y. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2753 · Cited by 2,192
Poly(ADP-ribose): novel functions for an old molecule
Schreiber, V., Dantzer, F., Ame, J.-C., & de Murcia, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1963 · Cited by 1,915
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
d'AMOURS, D., DESNOYERS, S., d'SILVA, I., & POIRIER, G. G. (1999) · Biochemical Journal · doi:10.1042/bj3420249 · Cited by 1,815
Cancer Susceptibility and the Functions of BRCA1 and BRCA2
Venkitaraman, A. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00615-3 · Cited by 1,713
The DNA Damage Response: Ten Years After
Harper, J. W., & Elledge, S. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.11.015 · Cited by 1,705 · cited 1×
“Cancer Cell 23, 693–704, May 13, 2013 ª2013 Elsevier Inc. 693 DNA damage sites (Harper and Elledge, 2007).”
Hallmarks of 'BRCAness' in sporadic cancers
Turner, N., Tutt, A., & Ashworth, A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1457 · Cited by 1,657
BRCA1 and BRCA2: different roles in a common pathway of genome protection
Roy, R., Chun, J., & Powell, S. N. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3181 · Cited by 1,469
PARP inhibition: PARP1 and beyond
Rouleau, M., Patel, A., Hendzel, M. J., Kaufmann, S. H., & Poirier, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2812 · Cited by 1,298
New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
Gibson, B. A., & Kraus, W. L. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3376 · Cited by 1,226
RNF8 Ubiquitylates Histones at DNA Double-Strand Breaks and Promotes Assembly of Repair Proteins
Mailand, N., Bekker-Jensen, S., Faustrup, H., Melander, F., Bartek, J., Lukas, C., & Lukas, J. (2007) · Cell · doi:10.1016/j.cell.2007.09.040 · Cited by 1,151
RNF8 Transduces the DNA-Damage Signal via Histone Ubiquitylation and Checkpoint Protein Assembly
Huen, M. S. Y., Grant, R., Manke, I., Minn, K., Yu, X., Yaffe, M. B., & Chen, J. (2007) · Cell · doi:10.1016/j.cell.2007.09.041 · Cited by 1,022
Self-citationHistone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks
Celeste, A., Fernandez-Capetillo, O., Kruhlak, M. J., Pilch, D. R., Staudt, D. W., Lee, A., Bonner, R. F., Bonner, W. M., & Nussenzweig, A. (2003) · Nature Cell Biology · doi:10.1038/ncb1004 · Cited by 989
Masson, M., Niedergang, C., Schreiber, V., Muller, S., Menissier-de Murcia, J., & de Murcia, G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3563 · Cited by 910
Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80503-6 · Cited by 900
Orchestration of the DNA-Damage Response by the RNF8 Ubiquitin Ligase
Kolas, N. K., Chapman, J. R., Nakada, S., Ylanko, J., Chahwan, R., Sweeney, F. D., Panier, S., Mendez, M., Wildenhain, J., Thomson, T. M., et al. (2007) · Science · doi:10.1126/science.1150034 · Cited by 894
The BRCT Domain Is a Phospho-Protein Binding Domain
Yu, X., Chini, C. C. S., He, M., Mer, G., & Chen, J. (2003) · Science · doi:10.1126/science.1088753 · Cited by 862
Self-citationPoly(ADP-ribosyl)ation by PARP-1: `PAR-laying' NAD+ into a nuclear signal
Kim, M. Y., Zhang, T., & Kraus, W. L. (2005) · Genes & Development · doi:10.1101/gad.1331805 · Cited by 802
Identification of a RING protein that can interact in vivo with the BRCA1 gene product
Wu, L. C., Wang, Z. W., Tsan, J. T., Spillman, M. A., Phung, A., Xu, X. L., Yang, M.-C. W., Hwang, L.-Y., Bowcock, A. M., & Baer, R. (1996) · Nature Genetics · doi:10.1038/ng1296-430 · Cited by 746
Abraxas and RAP80 Form a BRCA1 Protein Complex Required for the DNA Damage Response
Wang, B., Matsuoka, S., Ballif, B. A., Zhang, D., Smogorzewska, A., Gygi, S. P., & Elledge, S. J. (2007) · Science · doi:10.1126/science.1139476 · Cited by 695
Nuclear ADP-Ribosylation Reactions in Mammalian Cells: Where Are We Today and Where Are We Going?
Hassa, P. O., Haenni, S. S., Elser, M., & Hottiger, M. O. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00040-05 · Cited by 682
RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites
Sobhian, B., Shao, G., Lilli, D. R., Culhane, A. C., Moreau, L. A., Xia, B., Livingston, D. M., & Greenberg, R. A. (2007) · Science · doi:10.1126/science.1139516 · Cited by 674
Structural Basis for DNA Damage–Dependent Poly(ADP-ribosyl)ation by Human PARP-1
Langelier, M.-F., Planck, J. L., Roy, S., & Pascal, J. M. (2012) · Science · doi:10.1126/science.1216338 · Cited by 665
BRCT Repeats As Phosphopeptide-Binding Modules Involved in Protein Targeting
Manke, I. A., Lowery, D. M., Nguyen, A., & Yaffe, M. B. (2003) · Science · doi:10.1126/science.1088877 · Cited by 651
In search of the tumour-suppressor functions of BRCA1 and BRCA2
Scully, R., & Livingston, D. M. (2000) · Nature · doi:10.1038/35044000 · Cited by 643
Hashizume, R., Fukuda, M., Maeda, I., Nishikawa, H., Oyake, D., Yabuki, Y., Ogata, H., & Ohta, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000881200 · Cited by 634
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
D’Amours, D., Desnoyers, S., D’Silva, I., & Poirier, G. G. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3420249 · Cited by 599
Ubiquitin-Binding Protein RAP80 Mediates BRCA1-Dependent DNA Damage Response
Kim, H., Chen, J., & Yu, X. (2007) · Science · doi:10.1126/science.1139621 · Cited by 540
Self-citationPositional stability of single double-strand breaks in mammalian cells
Soutoglou, E., Dorn, J. F., Sengupta, K., Jasin, M., Nussenzweig, A., Ried, T., Danuser, G., & Misteli, T. (2007) · Nature Cell Biology · doi:10.1038/ncb1591 · Cited by 509
The macro domain is an ADP‐ribose binding module
Karras, G. I., Kustatscher, G., Buhecha, H. R., Allen, M. D., Pugieux, C., Sait, F., Bycroft, M., & Ladurner, A. G. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600664 · Cited by 505
BRCA1 and its toolbox for the maintenance of genome integrity
Huen, M. S. Y., Sy, S. M. H., & Chen, J. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2831 · Cited by 490
Koonin, E. V., Altschul, S. F., & Bork, P. (1996) · Nature Genetics · doi:10.1038/ng0796-266 · Cited by 368
Physiology and pathophysiology of poly(ADP‐ribosyl)ation *
Bürkle, A. (2001) · BioEssays · doi:10.1002/bies.1115 · Cited by 335
Shen, S.-X., Weaver, Z., Xu, X., Li, C., Weinstein, M., Chen, L., Guan, X.-Y., Ried, T., & Deng, C.-X. (1998) · Oncogene · doi:10.1038/sj.onc.1202243 · Cited by 329
Fisher, A. E. O., Hochegger, H., Takeda, S., & Caldecott, K. W. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02248-06 · Cited by 314
Spatial and Temporal Cellular Responses to Single-Strand Breaks in Human Cells
Okano, S., Lan, L., Caldecott, K. W., Mori, T., & Yasui, A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.11.3974-3981.2003 · Cited by 305
Spatial and Temporal Cellular Responses to Single-Strand Breaks in Human Cells
(2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.15.5472.2003 · Cited by 297
THE GENETICS OF BREAST CANCER SUSCEPTIBILITY
Rahman, N., & Stratton, M. R. (1998) · Annual Review of Genetics · doi:10.1146/annurev.genet.32.1.95 · Cited by 295
The zinc-finger domains of PARP1 cooperate to recognize DNA strand breaks
Ali, A. A. E., Timinszky, G., Arribas-Bosacoma, R., Kozlowski, M., Hassa, P. O., Hassler, M., Ladurner, A. G., Pearl, L. H., & Oliver, A. W. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2335 · Cited by 268
BRCA1 RING Function Is Essential for Tumor Suppression but Dispensable for Therapy Resistance
Drost, R., Bouwman, P., Rottenberg, S., Boon, U., Schut, E., Klarenbeek, S., Klijn, C., van der Heijden, I., van der Gulden, H., Wientjens, E., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.014 · Cited by 262
Clapperton, J. A., Manke, I. A., Lowery, D. M., Ho, T., Haire, L. F., Yaffe, M. B., & Smerdon, S. J. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb775 · Cited by 250
Stimulation of the DNA-dependent Protein Kinase by Poly(ADP-Ribose) Polymerase
Ruscetti, T., Lehnert, B. E., Halbrook, J., Le Trong, H., Hoekstra, M. F., Chen, D. J., & Peterson, S. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14461 · Cited by 248
Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains
Rodriguez, M., Yu, X., Chen, J., & Songyang, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300407200 · Cited by 234
Self-citationHu, Y., Scully, R., Sobhian, B., Xie, A., Shestakova, E., & Livingston, D. M. (2011) · Genes & Development · doi:10.1101/gad.2011011 · Cited by 233
Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1
Williams, R. S., Lee, M. S., Hau, D. D., & Glover, J. N. M. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb776 · Cited by 230
Abbott, D. W., Thompson, M. E., Robinson-Benion, C., Tomlinson, G., Jensen, R. A., & Holt, J. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18808 · Cited by 228
Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death
Ying, W., Sevigny, M. B., Chen, Y., & Swanson, R. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211202598 · Cited by 198
Thai, T. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.2.195 · Cited by 185
Double-strand DNA breaks recruit the centromeric histone CENP-A
Zeitlin, S. G., Baker, N. M., Chapados, B. R., Soutoglou, E., Wang, J. Y. J., Berns, M. W., & Cleveland, D. W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908233106 · Cited by 183
Fahrer, J., Kranaster, R., Altmeyer, M., Marx, A., & Bürkle, A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm944 · Cited by 161
Advances in using PARP inhibitors to treat cancer
Kummar, S., Chen, A. P., Parchment, R. E., Kinders, R. J., Ji, J., Tomaszewski, J. E., & Doroshow, J. H. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-25 · Cited by 151
Dunn, C., O’Handley, S., Frick, D. N., & Bessman, M. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32318 · Cited by 151
Mapping the Functional Domains of BRCA1
Meza, J. E., Brzović, P. S., King, M., & Klevit, R. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5659 · Cited by 142
Structural Basis of BACH1 Phosphopeptide Recognition by BRCA1 Tandem BRCT Domains
Botuyan, M. V., Nominé, Y., Yu, X., Juranić, N., Macura, S. I., Chen, J., & Mer, G. (2004) · Structure · doi:10.1016/j.str.2004.06.002 · Cited by 96
Self-citationInhibition of poly(ADP-ribose) glycohydrolase (PARG) specifically kills BRCA2-deficient tumor cells
Fathers, C., Drayton, R. M., Solovieva, S. E., & Bryant, H. E. (2012) · Cell Cycle · doi:10.4161/cc.11.5.19482 · Cited by 94
High Resolution Fractionation and Characterization of ADP-Ribose Polymers
Kiehlbauch, C. C., Aboul-Ela, N., Jacobson, E. L., Ringer, D. P., & Jacobson, M. K. (1993) · Analytical Biochemistry · doi:10.1006/abio.1993.1004 · Cited by 83
Mutational analysis of BARD1 in familial breast cancer patients in Japan
Ishitobi, M., Miyoshi, Y., Hasegawa, S., Egawa, C., Tamaki, Y., Monden, M., & Noguchi, S. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00387-2 · Cited by 74
Au, W. W. Y., & Henderson, B. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408879200 · Cited by 67
Crystal Structure of the BARD1 BRCT Domains,
Birrane, G., Varma, A. K., Soni, A., & Ladias, J. A. A. (2007) · Biochemistry · doi:10.1021/bi700323t · Cited by 59
Sauer, M. K., & Andrulis, I. L. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.030049 · Cited by 51
PARP inhibitors in breast cancer: BRCA and beyond.
Rios, J. A., & Puhalla, S. (2011) · PubMed · Cited by 50
Identification of Residues Required for the Interaction of BARD1 with BRCA1
Morris, J. R., Keep, N. H., & Solomon, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109249200 · Cited by 38
Cardiac volume overload rapidly induces oxidative stress-mediated myocyte apoptosis and hypertrophy
Fiorillo, C., Nediani, C., Ponziani, V., Giannini, L., Celli, A., Nassi, N., Formigli, L., Perna, A. M., & Nassi, P. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.03.015 · Cited by 34
Determination of intracellular concentrations of the TRPM2 agonist ADP-ribose by reversed-phase HPLC
Gasser, A. S., & Guse, A. H. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.05.002 · Cited by 24
Larrea, S. C. V., Alonso, G., Schlesinger, M., Torres, H. N., Flawiá, M. M., & Villamil, S. H. F. (2010) · International Journal for Parasitology · doi:10.1016/j.ijpara.2010.11.008 · Cited by 24
Cited by
The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
Ray Chaudhuri, A., & Nussenzweig, A. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.53 · Cited by 1,786
Ubiquitin ligases: structure, function, and regulation
Zheng, N., & Shabek, N. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014922 · Cited by 1,499
Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer
Konstantinopoulos, P. A., Ceccaldi, R., Shapiro, G. I., & D'Andrea, A. D. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0714 · Cited by 945
Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action
Pommier, Y., O’Connor, M. J., & de Bono, J. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf9246 · Cited by 739
PARP and PARG inhibitors in cancer treatment
Slade, D. (2020) · Genes & Development · doi:10.1101/gad.334516.119 · Cited by 667
Metadata
- Authors
- Li, M., & Yu, X.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 23
- Issue
- 5
- Pages
- 693-704
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2067818013
- Cited by
- 321
- References
- 69
- FWCI
- 11.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.